XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.2

REVENUE (Tables)

6 Months Ended

Jun. 30, 2024

Revenue from Contract with Customer [Abstract]

Schedule of disaggregation of revenue

The following table presents the Company’s revenues disaggregated by revenue source:

						Three Months Ended June 30,												Six Months Ended June 30,
(In thousands)						2024						2023						2024						2023
Screening
Medicare Parts B & C						$	195,337					$	176,016					$	369,127					$	347,746
Commercial						283,729						245,748						537,872						478,781
Other						52,540						41,023						99,405						79,455
Total Screening						531,606						462,787						1,006,404						905,982
Precision Oncology
Medicare Parts B & C						$	47,467					$	47,588					$	95,517					$	94,969
Commercial						49,187						46,212						95,887						91,144
International						46,722						35,586						91,255						72,854
Other						24,282						27,788						47,725						53,639
Total Precision Oncology						167,658						157,174						330,384						312,606
COVID-19 Testing						$	—					$	2,132					$	—					$	5,955
Total						$	699,264					$	622,093					$	1,336,788					$	1,224,543

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration